Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties

BACKGROUND: Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD) biosynthesis, is up-regulated in several cancers, including metastatic melanoma (MM). The BRAF oncogene is mutated in different cancer types, among which MM and thyroid car...

Descripción completa

Detalles Bibliográficos
Autores principales: Audrito, Valentina, Moiso, Enrico, Ugolini, Filippo, Messana, Vincenzo Gianluca, Brandimarte, Lorenzo, Manfredonia, Ilaria, Bianchi, Simonetta, De Logu, Francesco, Nassini, Romina, Szumera-Ciećkiewicz, Anna, Taverna, Daniela, Massi, Daniela, Deaglio, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908704/
https://www.ncbi.nlm.nih.gov/pubmed/35272691
http://dx.doi.org/10.1186/s12967-022-03315-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908704/
https://www.ncbi.nlm.nih.gov/pubmed/35272691
http://dx.doi.org/10.1186/s12967-022-03315-9

Ejemplares similares